RELEVANCE OF ORGANIC CATION TRANSPORTER OCT1 (SLC22A1) IN DIETHYLNITROSAMINE-INITIATED AND PHENOBARBITAL-PROMOTED HEPATOCELLULAR CARCINOMA IN OCT3-KNOCKOUT MICE

被引：0
|
作者：
Knapstein, J. [1 ]
Fuchs, P. [1 ]
Grimm, D. [1 ]
Lautem, A. [2 ]
Hoppe-Lotichius, M. [2 ]
Woerns, M. A. [1 ]
Lang, H. [2 ]
Galle, P. R. [1 ]
Zimmermann, T. [1 ]
机构：
[1] Univ Hosp Mainz, Ctr Cirrhosis Mainz, Dept Med 1, Mainz, Germany
[2] Univ Hosp Mainz, Dept Hepatoboliary & Transplantat Surg, Mainz, Germany
来源：
JOURNAL OF HEPATOLOGY | 2015年 / 62卷
关键词：
D O I：
10.1016/S0168-8278(15)30441-4
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P0222
引用
收藏
页码：S390 / S390
页数：1
相关论文
共 47 条
  • [1] Evaluation of organic cation transporter 1 (OCT1, SLC22A1) as transporter for sorafenib
    Neul, Claudia
    Baker, Sharyn D.
    Sparreboom, Alex
    Schaeffeler, Elke
    Laufer, Stefan
    Schwab, Matthias
    Nies, Anne T.
    [J]. CANCER RESEARCH, 2016, 76
  • [2] DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
    Schaeffeler, Elke
    Hellerbrand, Claus
    Nies, Anne T.
    Winter, Stefan
    Kruck, Stephan
    Hofmann, Ute
    van der Kuip, Heiko
    Zanger, Ulrich M.
    Koepsell, Hermann
    Schwab, Matthias
    [J]. GENOME MEDICINE, 2011, 3
  • [3] DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma
    Elke Schaeffeler
    Claus Hellerbrand
    Anne T Nies
    Stefan Winter
    Stephan Kruck
    Ute Hofmann
    Heiko van der Kuip
    Ulrich M Zanger
    Hermann Koepsell
    Matthias Schwab
    [J]. Genome Medicine, 3
  • [4] Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
    Heise, Michael
    Lautem, Anja
    Knapstein, Johanna
    Schattenberg, Joern M.
    Hoppe-Lotichius, Maria
    Foltys, Daniel
    Weiler, Nina
    Zimmermann, Anca
    Schad, Arno
    Gruendemann, Dirk
    Otto, Gerd
    Galle, Peter R.
    Schuchmann, Marcus
    Zimmermann, Tim
    [J]. BMC CANCER, 2012, 12
  • [5] DOWNREGULATION OF ORGANIC CATION TRANSPORTERS OCT1 (SLC22A1) AND OCT3 (SLC22A3) IN HUMAN HEPATOCELLULAR CARCINOMA AND THEIR PROGNOSTIC SIGNIFICANCE
    Knapstein, J.
    Heise, M.
    Lautem, A.
    Schattenberg, J.
    Galle, P. R.
    Otto, G.
    Schuchmann, M.
    Zimmermann, T.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S118 - S118
  • [6] Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
    Michael Heise
    Anja Lautem
    Johanna Knapstein
    Jörn M Schattenberg
    Maria Hoppe-Lotichius
    Daniel Foltys
    Nina Weiler
    Anca Zimmermann
    Arno Schad
    Dirk Gründemann
    Gerd Otto
    Peter R Galle
    Marcus Schuchmann
    Tim Zimmermann
    [J]. BMC Cancer, 12
  • [7] INTERINDIVIDUAL VARIABILITY OF ORGANIC CATION TRANSPORTER OCT1 (SLC22A1) AND OCT3 (SLC22A3) EXPRESSION IN HUMAN LIVER
    Nies, Anne T.
    Schaeffeler, Elke
    Klein, Kathrin
    Zanger, Ulrich M.
    Kerb, Reinhold
    Koepsell, Hermann
    Keppler, Dietrich
    Schwab, Matthias
    [J]. DRUG METABOLISM REVIEWS, 2008, 40 : 153 - 154
  • [8] ORGANIC CATION TRANSPORTER 1 (OCT1; SLC22A1) MODULATES HEPATIC ENERGY METABOLISM
    Liang, X.
    Luo, Q.
    Yee, S.
    Chen, E. C.
    Chien, H. -C.
    King, S.
    Giacomini, K. M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S8 - S8
  • [9] Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1)
    Chen, Eugene C.
    Khuri, Natalia
    Liang, Xiaomin
    Stecula, Adrian
    Chien, Huan-Chieh
    Yee, Sook Wah
    Huang, Yong
    Sali, Andrej
    Giacomini, Kathleen M.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (07) : 2685 - 2696
  • [10] Impact of Promoter Polymorphisms on the Transcriptional Regulation of the Organic Cation Transporter OCT1 (SLC22A1)
    Bokelmann, Kristin
    Brockmoeller, Juergen
    Tzvetkov, Mladen, V
    [J]. JOURNAL OF PERSONALIZED MEDICINE, 2018, 8 (04):
12345